CurveBeam AIASX:CVB -3.85% PS Ratio is 0.81 as of Jul. 01, 2026, which is 70% below its 10-year median of 2.72. The stock has 5 warning signs investors should review. Among 805 Medical Devices & Instruments companies, CurveBeam AI ranks better than 84.1% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, CurveBeam AI's share price is A$0.025.
CurveBeam AI's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.03. Hence, CurveBeam AI's PS Ratio for today is 0.81.
Good Sign:
CurveBeam AI Ltd stock PS Ratio (=0.84) is close to 3-year low of 0.84.
The historical rank and industry rank for CurveBeam AI's PS Ratio or its related term are showing as below:
ASX:CVB'
s PS Ratio Range Over the Past 10 Years
Min: 0.81 Med: 2.72 Max: 10.76
Current: 0.81
During the past 5 years, CurveBeam AI's highest PS Ratio was 10.76. The lowest was 0.81. And the median was 2.72.
ASX:CVB's PS Ratio is ranked better than 84.1% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 2.94
vs ASX:CVB: 0.81
During the past 12 months, the average Revenue per Share Growth Rate of CurveBeam AI was 34.80% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 13.30% per year.
During the past 5 years, CurveBeam AI's highest 3-Year average Revenue per Share Growth Rate was 13.30% per year. The lowest was 0.00% per year. And the median was 6.65% per year.
Back to Basics: PS Ratio
CurveBeam AI (ASX:CVB) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
CurveBeam AI PS Ratio Related Terms
CurveBeam AI PS Ratio Historical Data
* Premium members only.
The historical data trend for CurveBeam AI's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, CurveBeam AI's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CurveBeam AI PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, CurveBeam AI's PS Ratio distribution charts can be found below:
* The bar in red indicates where CurveBeam AI's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
CurveBeam AI's PS Ratio for today is calculated as
CurveBeam AI's Share Price of today is A$0.025.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. CurveBeam AI's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.03.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
CurveBeam AI (ASX:CVB) has a PS Ratio of 0.81 as of Jul. 01, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on CurveBeam AI and its competitors. This is 70% below median its historical median of 2.72. Over the past decade, CurveBeam AI's PS Ratio has ranged from 0.81 to 10.76. According to the industry distribution chart, CurveBeam AI ranks #128 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 15.9%.
Is CurveBeam AI's PS Ratio too high?
CurveBeam AI's current PS Ratio of 0.81 is 70% below median its 10-year median of 2.72. Over the past 10 years, this metric has ranged from a low of 0.81 to a high of 10.76. The Medical Devices & Instruments industry median PS Ratio is 2.94. CurveBeam AI's value of 0.81 is 72.4% below this industry median. Based on the distribution chart, CurveBeam AI ranks #128 out of 805 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does CurveBeam AI's PS Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, CurveBeam AI ranks #128 out of 805 companies for PS Ratio. This places CurveBeam AI in the top 16% of its industry — outperforming the majority of peers. The industry median PS Ratio is 2.94. CurveBeam AI's value of 0.81 is 72.4% below this benchmark. Historically, CurveBeam AI's own PS Ratio has ranged from 0.81 to 10.76 over the past decade. While the company's 10-year median is 2.72 vs. the industry median of 2.94, CurveBeam AI has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.94, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CurveBeam AI's current PS Ratio of 0.81 is 72.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on CurveBeam AI and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CurveBeam AI's current PS Ratio is 0.81, which is 70% below median its own 10-year median of 2.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CurveBeam AI stock overvalued right now?
CurveBeam AI (ASX:CVB) has a current PS Ratio of 0.81. The current PS Ratio is 0.81, which is 70% below median its 10-year median of 2.72 and 72.4% below the Medical Devices & Instruments industry median of 2.94. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For CurveBeam AI (ASX:CVB), the current PS Ratio is 0.81 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the company's CT devices to assist in the clinical assessment. The company has one operating segment, being the research, design, manufacture and sale of cone beam CT imaging equipment for orthopaedic specialties, which includes the development, validation and preparation for commercialisation of a HRpQCT Medical Device and Software as a Service (SaaS) platform.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:CVB has been successfully added to your 